Fundraising Fox2Flo Ventures — 2019 Investments
1 investments dated 2019 · listed companies and verified rows first · show all
Temprian Therapeuticstempriantherapeutics.comin𝕏Jan 2019
Temprian Therapeutics is a biopharmaceutical company developing an HSP70i-based immunotherapy for vitiligo.
BiotechDigital HealthHealthtechChicago, US
Isabelle Caroline Le Poole(Executive Officer, Director)Caroline Le Poole(CSO & Co-Founder)inSumeet Dagar(CEO)inPaul Burton(CFO & Board Member)inJohn Nieland(Chief Innovation Officer)inKettil Cedercreutz(Board Member & Co-Founder)in
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.